You are right. It is obvious to most people that there is either a conflict/incentive issue here to recommend this scheme or something is terribly wrong with the company that we don't now about. They state uncertainty with regard to "Pushpay’s forecast earnings for the financial years ending 31 March 2022 to 31 March 2027"! 2027? Of course there is uncertainty until 2027.
Logically ACC will vote against this, but not sure what the other 3-4 non-bidding large shareholders will do. BGH is a tough acquirer.. see what they did during the bidding war for that health company (Vitrus health or something like that was the name of it).
I think the board has lost credibility and if the scheme does not pass we should look into changing all of them. Anyway, I am too small to do anything here other than voting against the scheme for now.
PPH Price at posting:
$1.14 Sentiment: Hold Disclosure: Held
